Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of choi versus recist criteria (cripnet_ getne1504 study)

HIGHLIGHTS

• who: Mª Pilar Solis-Hernandez from the Department Universidad de Chile Anderson Cancer Center, Madrid, Spain have published the research work: Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study), in the Journal: (JOURNAL) of 16/05/2019
• what: The aim of the study was to assess the association of RECIST v1.1 and Choi criteria on survival endpoints.
• how: The reader must likewise be aware that while certain minimum quality criteria were required and 22 cases were excluded on the basis of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.